相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: An updated systematic review and meta-analysis
Changcheng Shi et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
J. Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
Lindsay M. Avery et al.
CLINICAL INFECTIOUS DISEASES (2019)
Neutrophil Extracellular Traps Enhance Staphylococcus Aureus Vegetation Formation through Interaction with Platelets in Infective Endocarditis
Chih-Chieh Hsu et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Pharmacodynamics of daptomycin in combination with other antibiotics for the treatment of enterococcal bacteraemia
Lindsay M. Avery et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Efficacy of Daptomycin Monotherapy and In Combination with β-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect
Razieh Kebriaei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Combatting resistant enterococcal infections: a pharmacotherapy review
Nicholas J. Mercuro et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis
Sophie Reissier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
Yu-Chung Chuang et al.
SCIENTIFIC REPORTS (2018)
Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients
Nicholas S. Britt et al.
CLINICAL INFECTIOUS DISEASES (2017)
Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis
J. M. Pericas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Model systems for the study of Enterococcal colonization and infection
H. M. Sharon Goh et al.
VIRULENCE (2017)
Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia
Yu-Chung Chuang et al.
CLINICAL INFECTIOUS DISEASES (2017)
Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents
Miao Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Bhavarth S. Shukla et al.
CLINICAL INFECTIOUS DISEASES (2016)
Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
Y-C. Chuang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
A Current Perspective on Daptomycin for the Clinical Microbiologist
Romney M. Humphries et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry
I-Lin Tsai et al.
TALANTA (2013)
How to calculate sample size in animal studies?
Jaykaran Charan et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
C. Garrigos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
Sujata M. Bhavnani et al.
CLINICAL INFECTIOUS DISEASES (2010)
Management of multidrug-resistant enterococcal infections
C. A. Arias et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus
O. Murillo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Therapeutic options for infections due to vancomycin-resistant enterococci
Jiun-Ling Wang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Biofilm formation by enterococci
Jamal A. Mohamed et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2007)
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci
Jacques Vouillamoz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
Mark Benvenuto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis
CA DiazGranados et al.
CLINICAL INFECTIOUS DISEASES (2005)
In vivo pharmacodynamic activity of daptomycin
N Safdar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
BH Dvorchik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Animal model pharmacokinetics and pharmacodynamics: a critical review
D Andes et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection
A Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
MJ Rybak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Drug therapy: Vancomycin-resistant enterococcal infections.
BE Murray
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
